Printer Friendly
The Free Library
14,635,145 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

American Cancer Society and Amgen Announce Patient Education Partnership; Information On Chemotherapy Principles Now Available Online.


ATLANTA--(BUSINESS WIRE)--Sept. 23, 1999--

The American Cancer Society American Cancer Society,
n.pr established in 1913, this national volunteer-based health organization is committed to the elimination of cancer through prevention and treatment and to diminishing cancer suffering through advocacy, scholarship, research,
, the nation's leading voluntary health organization and the preeminent pre·em·i·nent or pre-em·i·nent  
adj.
Superior to or notable above all others; outstanding. See Synonyms at dominant, noted.



[Middle English, from Latin prae
 source of cancer information and service, and Amgen, the world's largest independent biotechnology company, have joined forces to provide cancer patients and their caregivers with the credible, accurate and timely information they need to make informed decisions about cancer treatment.

Beginning today for the first time, cancer patients and their caregivers can visit the Society's web site, www.cancer.org, to access "Chemotherapy chemotherapy (kē'mōthĕr`əpē), treatment of disease with chemicals or drugs. One chemotherapeutic approach is the development of selectively toxic substances, i.e.  Principles," a peer-reviewed, yet patient-friendly article that explains how chemotherapy works. The article also provides useful information about the side effects Side effects

Effects of a proposed project on other parts of the firm.
 of chemotherapy designed to help patients successfully complete their course of treatment.

The American Cancer Society's collaboration with Amgen is part of the organization's strategic program to develop its own proprietary cancer drug database that will eventually be linked to a variety of patient education materials and external pharmaceutical sites. In this way, patients and caregivers will be able to make the most informed treatment decisions possible through access to enhanced information on various classes of drugs that can be used to treat cancer, while having easy access to additional background through a comprehensive system of internet links.

The American Cancer Society and Amgen developed the chemotherapy content in collaboration with independent physician experts and a nationwide editorial advisory panel of oncologists.

"By itself, the American Cancer Society lacks the resources to fully share the cancer education message with all of those in need," said Harmon Eyre, MD, executive vice president for research and medical affairs for the American Cancer Society. "However, pharmaceutical companies like Amgen have the resources and expertise in communicating cancer therapies. This expertise, combined with the American Cancer Society's credibility and access to millions of cancer patients, creates a powerful synergy The enhanced result of two or more people, groups or organizations working together. In other words, one and one equals three! It comes from the Greek "synergia," which means joint work and cooperative action.  that benefits everyone."

"We are very pleased to join with the American Cancer Society to provide the many patients receiving chemotherapy with important information on cancer and its treatment," said Gordon Binder Gordon Binder is currently managing director of Coastview Capital, LLC, and previously was chairman of Amgen[1]. He joined Amgen in 1982, and previously had executive roles at the United Geophysical Corporation and the System Development Corporation. , Amgen's chairman and chief executive officer. Mr. Binder binder: see combine.


An earlier Microsoft Office workbook file that let users combine related documents from different Office applications. The documents could be viewed, saved, opened, e-mailed and printed as a group.
 currently serves as a trustee of the American Cancer Society Foundation.

Amgen is a global biotechnology company that discovers, develops, manufactures and markets cost-effective human therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
 based on advances in cellular and molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller .

For more information about Amgen visit the company web site at www.cancer.org.

The American Cancer Society is the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer, through research, education, advocacy and service.

For information about cancer, call toll-free anytime 1-800-ACS-2345 or visit the American Cancer Society website at www.cancer.org.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 23, 1999
Words:441
Previous Article:MarkeTVision Direct, Inc. Completes Convertible Debenture Private Placement.
Next Article:Harrier Capital Corporation Announces Lock Up Agreement For Major Transaction.
Topics:



Related Articles
Analysts Downgrade Amgen Despite Good Results.(shares of Amgen Inc.)(Brief Article)
AMGEN SUBMITS ANEMIA THERAPY VARIATION APPLICATION TO EMEA.
AMGEN WINS APPROVAL FOR NEW DRUG NEULASTA ADDS VALUE TO FIRM.(Business)
AMGEN RISE BIOTECH COMPANY CREATES ITS OWN BOOM.(Business)
AMGEN'S CANCER DRUG TESTING WELL.(Business)
AMGEN STOPS CANCER TRIALS.(BUSINESS)
DRUG MAY AID CANCER TREATMENT : AMGEN SUBSTANCE LESSENS SIDE EFFECTS.(News)
LOWE MAKING PITCH FOR AMGEN CHEMOTHERAPY DRUG.(Business)
CANCER-DRUG SUCCESS AMGEN REMEDY STAVING OFF DISEASE.(Business)
Amgen shares recover slightly after spate of bad news: Thousand Oaks company cedes title as largest to Genentech.(STOCKS)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles